- GRIT
- Posts
- Slimming Down Sleep Issues
Slimming Down Sleep Issues
Eli Lilly, Tesla, ECB
Good Morning!
Happy Wednesday! Let’s see what is moving markets:
👉 Eli Lilly takes on sleep
👉 Tesla fights Delaware
👉ECB rate cuts soon
🚨 Announcement! 🚨
Did you hear? We are dropping a NEW email course!
Discover the keys to diversified investing with our dynamic email course designed for all investors seeking to broaden their portfolio horizons. While the tech sector continues to thrive (up 114% in the last five years as of April 10, 2024), our course offers a refreshing shift in focus, guiding you through the intricacies of investing across various stock market sectors.
📥 Get ready to enroll!
TREATMENT: Sleep Apnea
Eli Lilly announced on Wednesday that its weight loss drug Zepbound could potentially treat obstructive sleep apnea which is the most common sleep-related breathing disorder. This based on promising results from two advanced clinical trials. Despite high costs and limited insurance coverage, demand for the drug has surged due to its benefits for weight loss and diabetes management. The drug was more effective than a placebo in reducing symptoms of obstructive sleep apnea (OSA) in obese patients over a year, according to preliminary data.
Source: Reuters
Eli Lilly plans to present these results at an upcoming medical conference and seek approvals from the U.S. Food and Drug Administration and other international regulators. The FDA has already given Zepbound a fast-track designation for treating moderate-to-severe OSA in obese patients, which speeds up the review process.
🎯 GRIT TAKE: This development offers…upgrade to VIP now to read the full GRIT Take!
MUSK: $56 Billion Compensation
Tesla announced on Wednesday that it plans to ask shareholders to reinstate CEO Elon Musk's $56 billion compensation package, which was previously voided by a Delaware judge. The announcement was made in a preliminary proxy filing shortly after Tesla informed employees of a 10% workforce reduction.
Source: ABC
The company views the court ruling as a significant issue and also intends to propose relocating its state of incorporation from Delaware to Texas. However, these proposals are expected to be controversial. Tesla has re-engaged the proxy solicitor Innisfree M&A, which it last used in 2018, to help secure shareholder votes for these initiatives. The company expects to spend millions on this effort.
ECB: Rate Cuts
European Central Bank President Christine Lagarde said on Tuesday that the bank plans to cut interest rates soon, as long as there are no major disruptions. She noted that the ECB is closely watching oil prices due to potential conflicts in the Middle East, but the response to recent tensions has been moderate.
Source: CNBC
She made these comments after the bank indicated it might start reducing rates at its June meeting. Last Thursday, the ECB kept interest rates high but suggested cuts could be coming because inflation is decreasing. Lagarde did not comment on whether three rate cuts this year would be reasonable.
Headlines You Need To Know: 🎙
Chart of the Day
📊 Bitcoin vs. Nasdaq 3X Leverage
Source: Bloomberg, Tavi Costa
GRIT Meme of the Day 😂
Tag GRIT Capital on social media for a chance to be featured in our meme or Tweet of the day in our GRIT daily newsletter! 👇
Source: @wallstbets
The author, publisher or insiders of the publisher may currently have long or short positions in the securities of the companies mentioned herein, or may have such a position in the future (and therefore may profit from fluctuations in the trading price of the securities). To the extent such persons do have such positions, there is no guarantee that such persons will maintain such positions.
Grit is a publisher of financial information, not an investment advisor. Grit does not provide personalized or individualized investment advice or information that is tailored to the needs of any particular recipient. Grit does not guarantee the accuracy or completeness of the information provided in this page. All statements and expressions herein are the sole opinion of the author or paid advertiser.
THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, AND DOES NOT PURPORT TO BE AND DOES NOT EXPRESS ANY OPINION AS TO THE PRICE AT WHICH THE SECURITIES OF ANY COMPANY MAY TRADE AT ANY TIME. THE INFORMATION AND OPINIONS PROVIDED HEREIN SHOULD NOT BE TAKEN AS SPECIFIC ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. INVESTORS SHOULD MAKE THEIR OWN INVESTIGATION AND DECISIONS REGARDING THE PROSPECTS OF ANY COMPANY DISCUSSED HEREIN BASED ON SUCH INVESTORS’ OWN REVIEW OF PUBLICLY AVAILABLE INFORMATION AND SHOULD NOT RELY ON THE INFORMATION CONTAINED HEREIN. INVESTORS SHOULD OBTAIN INDIVIDUAL INVESTMENT ADVICE BASED ON THEIR OWN CIRCUMSTANCES BEFORE MAKING AN INVESTMENT DECISION
No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned.
The author, publisher or insiders of the publisher may currently have long or short positions in the securities of the companies mentioned herein, or may have such a position in the future (and therefore may profit from fluctuations in the trading price of the securities). To the extent such persons do have such positions, there is no guarantee that such persons will maintain such positions.
Any projections, market outlooks or estimates herein are forward looking statements and are inherently unreliable. They are based upon certain assumptions and should not be construed to be indicative of the actual events that will occur. Other events that were not taken into account may occur and may significantly affect the returns or performance of the securities discussed herein. The information provided herein is based on matters as they exist as of the date of preparation and not as of any future date, and Grit undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional material.
Grit does not accept any liability whatsoever for any direct or consequential loss, however arising, directly or indirectly, from any use of the information contained herein.
By using the Site or any related social media account, you are indicating your consent and agreement to this disclaimer and our terms of use. Unauthorized reproduction of this newsletter or its contents by photocopy, facsimile or any other means is illegal and punishable by law.
Please read: Terms of Use, Privacy Policy, Disclosure Policy, State Disclosure Policy, and Disclaimer Policy
If you have any questions please contact us at info@gritcap.io
Reply